AI MARKET SCANNING

ARS Pharmaceuticals Inc

📅 Next Catalyst: Nov 10, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.73%
MAX GAP RECORD -16.39%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $SPRY
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 10, 2026 Earnings Release 2026-11-10 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 13, 2026 Earnings Release 2026-08-13 (AFTER CLOSE)
-16.39%
May 15, 2026 Earnings Release 2026-05-15 (BEFORE OPEN)
-6.80%
Mar 09, 2026 Earnings Release 2026-03-09 (BEFORE OPEN)
+3.09%
Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN)
+12.99%
Aug 13, 2025 Earnings Release 2025-08-13 (UNDETERMINED)
+0.00%
May 14, 2025 Earnings Release 2025-05-14 (BEFORE OPEN)
-8.16%
Mar 20, 2025 Earnings Release 2025-03-20 (BEFORE OPEN)
+5.58%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.1%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $SPRY

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗